The strength of the TheraMe!'s team is its interdisciplinary


Our team includes University Professors in Microfluidics, Bioinformatics and Clinical Oncology, as well as experts in entrepreneurship, business administration, physics and biomedical sciences.

Christoph is a professor for biomedical microfluidics at EPFL and holds an adjunct position at the Ludwig Institute for Cancer Research. In parallel to his academic career,christoph has successfully commercialized microfluidic technology for genomic applications and collaborated with big pharma. Furthermore, he is a cofounder and CSO of Velabs Therapeutics.
Prof. Christoph A. Merten
Swiss Federal Institute of Technology Lausanne (EPFL), Ludwig Institute for Cancer Research Adjunct scientist.
Expert in biomedical microfluidics
Julio is a professor of Medical Bioinformatics and Data Analysis at the Medical Faculty of Heidelberg University, Director of the Institute for Computational Biomedicine, Group Leader of the Molecular Medicine Partnership Unit at EMBL University Heidelberg and Co-Director of DREAM challenges. He collaborates with biomedical groups in academia and industry.
Prof. Julio Saez-Rodriguez
Medical Faculty of Heidelberg University.
Expert in bioinformatics, personalized medicine and cellular modelling
Thorsten is a Professor of Molecular Tumour Biology at RWTH Aachen University (Germany) and Maastricht University (the Netherlands). He is a also certified specialist in internal medicine and is involved in both the clinical care of cancer patients and basic research in tumour biology.
Prof. Dr. Med. Thorsten Cramer
RWTH Aachen University Hospital.
Expert in experimental cancer research
Federica is an Assistant Professor of Systems Biology for Oncology at Eindhoven University of Technology in the Netherlands. She is an expert in personalized cancer therapies. Her approach combines both data science and experimental methods. She is the lead author of numerous articles in high-impact journals.
Prof. Federica Eduati
Eindhoven Technical University
Expert in Biomedical Engineering and computational biology
Ulf was trained as an oncological and transplant surgeon at the Charité Berlin. Actually, Ulf is the head of department of surgery at Aachen RWTH and additionally MUMC Maastricht in a joined position. He has successfully introduced and participated in a large number of clinically studies in cancer and transplantation research collaborating with academic research programs and also big pharma.
Prof Dr. Med. Ulf Neumann
RWTH Aachen University Hospital.
Clinical Director
Vida has 15 years of research experience in tumor biomarkers, signal transduction, chemotherapy resistance and immuno-oncology. She has expertise in preclinical cancer research and is an experienced project manager. She leads the project in vivo validation unit.
Dr. Vida Vafaizadeh
Swiss Federal Institute of Technology Lausanne (EPFL), School of Engineering, Department of Bioengineering.
Head of clinical development
Hana is an EPFL Micro-engineer with entrepreneurial background in tech driven innovation. she has collaborated with successful startups in the medical device space. As a previous medtech startup founder, she has hands-on experience of both product development and venture strategies. She leads the project's technology development unit.
Hana Samet
Swiss Federal Institute of Technology Lausanne (EPFL), School of Engineering, Department of Bioengineering.
Head of microfluidic tech development
Hien is a molecular biologist by training. She has been working on cellular genetics and transcriptomics explaining individual differences in circadian traits that are often disrupted in human diseases. She leads the transcriptomic unit.
Dr. Ngoc-Hien DU
Swiss Federal Institute of Technology Lausanne (EPFL), School of Engineering, Department of Bioengineering.
Head of sequencing technologies
Ramesh previously worked as project manager for TheraME! His main expertise is in the development of microfluidic technologies and instrument control software.
Ramesh Utharala, MBA
Wenwei holds a PhD degree in biochemistry and molecular biology from University of Lincoln UK. She has abundant experience of working in academia and industry in the field of In Vitro Diagnostics (IVD).
Dr. Wenwei Ma